Omicron Vaccine Could Get Approval In 3-4 Months: EU

Omicron Vaccine: EU has so far approved four vaccines for use for adults in the EU: Pfizer-BioNTech, Moderna, AstraZeneca and Johnson & Johnson.

Vaccines specially adapted for the new Omicron coronavirus variant could be approved in three to four months if they are needed, the head of the EU's drug regulator said on Tuesday.

The decision on whether new shots are required would, however, have to be made by other bodies, European Medicines Agency Executive Director Emer Cooke said.

"Were there a need to change the existing vaccines, we could be in a position to have those approved within three to four months," Cooke told a European Parliament committee.

"That's from the start of the time when they would start to change."